nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP2A6—Pilocarpine—glaucoma	0.11	0.182	CbGbCtD
Buprenorphine—CYP2D6—Carteolol—glaucoma	0.0455	0.0754	CbGbCtD
Buprenorphine—CYP1A2—Betaxolol—glaucoma	0.0373	0.0618	CbGbCtD
Buprenorphine—CYP2D6—Betaxolol—glaucoma	0.0308	0.0509	CbGbCtD
Buprenorphine—CYP2C19—Methazolamide—glaucoma	0.0307	0.0508	CbGbCtD
Buprenorphine—CYP2C9—Diclofenamide—glaucoma	0.0296	0.049	CbGbCtD
Buprenorphine—CYP2C9—Dorzolamide—glaucoma	0.0286	0.0474	CbGbCtD
Buprenorphine—CYP3A5—Clonidine—glaucoma	0.0275	0.0455	CbGbCtD
Buprenorphine—CYP2C19—Timolol—glaucoma	0.0261	0.0432	CbGbCtD
Buprenorphine—CYP2C9—Methazolamide—glaucoma	0.0255	0.0422	CbGbCtD
Buprenorphine—CYP2D6—Methazolamide—glaucoma	0.0233	0.0386	CbGbCtD
Buprenorphine—CYP3A4—Pilocarpine—glaucoma	0.0219	0.0363	CbGbCtD
Buprenorphine—ABCB1—Timolol—glaucoma	0.021	0.0348	CbGbCtD
Buprenorphine—CYP1A2—Clonidine—glaucoma	0.0205	0.0339	CbGbCtD
Buprenorphine—CYP2D6—Timolol—glaucoma	0.0198	0.0328	CbGbCtD
Buprenorphine—ABCB1—Clonidine—glaucoma	0.0179	0.0296	CbGbCtD
Buprenorphine—CYP3A4—Brinzolamide—glaucoma	0.0172	0.0285	CbGbCtD
Buprenorphine—CYP2D6—Clonidine—glaucoma	0.0169	0.0279	CbGbCtD
Buprenorphine—CYP3A4—Dorzolamide—glaucoma	0.0166	0.0275	CbGbCtD
Buprenorphine—CYP3A4—Methazolamide—glaucoma	0.0148	0.0245	CbGbCtD
Buprenorphine—CYP3A4—Acetazolamide—glaucoma	0.0119	0.0196	CbGbCtD
Buprenorphine—CYP3A4—Clonidine—glaucoma	0.0107	0.0177	CbGbCtD
Buprenorphine—Feeling abnormal—Travoprost—glaucoma	0.000171	0.000513	CcSEcCtD
Buprenorphine—Conjunctivitis—Timolol—glaucoma	0.00017	0.000511	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Dorzolamide—glaucoma	0.00017	0.000511	CcSEcCtD
Buprenorphine—Palpitations—Clonidine—glaucoma	0.00017	0.000511	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00017	0.00051	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Travoprost—glaucoma	0.00017	0.000509	CcSEcCtD
Buprenorphine—Loss of consciousness—Clonidine—glaucoma	0.000169	0.000508	CcSEcCtD
Buprenorphine—Feeling abnormal—Brinzolamide—glaucoma	0.000169	0.000506	CcSEcCtD
Buprenorphine—Mental disorder—Betaxolol—glaucoma	0.000169	0.000506	CcSEcCtD
Buprenorphine—Pain—Pilocarpine—glaucoma	0.000168	0.000505	CcSEcCtD
Buprenorphine—Constipation—Pilocarpine—glaucoma	0.000168	0.000505	CcSEcCtD
Buprenorphine—Cough—Clonidine—glaucoma	0.000168	0.000504	CcSEcCtD
Buprenorphine—Sweating—Timolol—glaucoma	0.000168	0.000504	CcSEcCtD
Buprenorphine—Dizziness—Apraclonidine—glaucoma	0.000168	0.000504	CcSEcCtD
Buprenorphine—Erythema—Betaxolol—glaucoma	0.000168	0.000503	CcSEcCtD
Buprenorphine—Malnutrition—Betaxolol—glaucoma	0.000168	0.000503	CcSEcCtD
Buprenorphine—Urticaria—Dorzolamide—glaucoma	0.000166	0.000496	CcSEcCtD
Buprenorphine—Body temperature increased—Dorzolamide—glaucoma	0.000165	0.000494	CcSEcCtD
Buprenorphine—Abdominal pain—Dorzolamide—glaucoma	0.000165	0.000494	CcSEcCtD
Buprenorphine—Tension—Betaxolol—glaucoma	0.000165	0.000494	CcSEcCtD
Buprenorphine—Sinusitis—Timolol—glaucoma	0.000164	0.000493	CcSEcCtD
Buprenorphine—Dysgeusia—Betaxolol—glaucoma	0.000164	0.000493	CcSEcCtD
Buprenorphine—Arthralgia—Clonidine—glaucoma	0.000164	0.000492	CcSEcCtD
Buprenorphine—Chest pain—Clonidine—glaucoma	0.000164	0.000492	CcSEcCtD
Buprenorphine—Abdominal pain—Travoprost—glaucoma	0.000164	0.000492	CcSEcCtD
Buprenorphine—Anxiety—Clonidine—glaucoma	0.000163	0.00049	CcSEcCtD
Buprenorphine—Asthenia—Acetazolamide—glaucoma	0.000163	0.000489	CcSEcCtD
Buprenorphine—Dizziness—Bimatoprost—glaucoma	0.000163	0.000489	CcSEcCtD
Buprenorphine—Nervousness—Betaxolol—glaucoma	0.000163	0.000489	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000163	0.000489	CcSEcCtD
Buprenorphine—Urticaria—Brinzolamide—glaucoma	0.000163	0.000488	CcSEcCtD
Buprenorphine—Feeling abnormal—Pilocarpine—glaucoma	0.000162	0.000487	CcSEcCtD
Buprenorphine—Discomfort—Clonidine—glaucoma	0.000162	0.000486	CcSEcCtD
Buprenorphine—Vomiting—Apraclonidine—glaucoma	0.000162	0.000485	CcSEcCtD
Buprenorphine—Muscle spasms—Betaxolol—glaucoma	0.000161	0.000484	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000161	0.000483	CcSEcCtD
Buprenorphine—Hypersensitivity—Brimonidine—glaucoma	0.000161	0.000482	CcSEcCtD
Buprenorphine—Dry mouth—Clonidine—glaucoma	0.00016	0.000481	CcSEcCtD
Buprenorphine—Bradycardia—Timolol—glaucoma	0.00016	0.000481	CcSEcCtD
Buprenorphine—Dermatitis—Apraclonidine—glaucoma	0.00016	0.00048	CcSEcCtD
Buprenorphine—Headache—Apraclonidine—glaucoma	0.000159	0.000477	CcSEcCtD
Buprenorphine—Confusional state—Clonidine—glaucoma	0.000159	0.000475	CcSEcCtD
Buprenorphine—Vision blurred—Betaxolol—glaucoma	0.000158	0.000474	CcSEcCtD
Buprenorphine—Rhinitis—Timolol—glaucoma	0.000158	0.000473	CcSEcCtD
Buprenorphine—Oedema—Clonidine—glaucoma	0.000157	0.000472	CcSEcCtD
Buprenorphine—Tremor—Betaxolol—glaucoma	0.000157	0.000471	CcSEcCtD
Buprenorphine—Hallucination—Timolol—glaucoma	0.000157	0.00047	CcSEcCtD
Buprenorphine—Asthenia—Brimonidine—glaucoma	0.000157	0.000469	CcSEcCtD
Buprenorphine—Infection—Clonidine—glaucoma	0.000156	0.000468	CcSEcCtD
Buprenorphine—Abdominal pain—Pilocarpine—glaucoma	0.000156	0.000467	CcSEcCtD
Buprenorphine—Body temperature increased—Pilocarpine—glaucoma	0.000156	0.000467	CcSEcCtD
Buprenorphine—Ill-defined disorder—Betaxolol—glaucoma	0.000156	0.000467	CcSEcCtD
Buprenorphine—Diarrhoea—Acetazolamide—glaucoma	0.000156	0.000466	CcSEcCtD
Buprenorphine—Rash—Bimatoprost—glaucoma	0.000155	0.000466	CcSEcCtD
Buprenorphine—Dermatitis—Bimatoprost—glaucoma	0.000155	0.000466	CcSEcCtD
Buprenorphine—Oedema peripheral—Timolol—glaucoma	0.000155	0.000465	CcSEcCtD
Buprenorphine—Shock—Clonidine—glaucoma	0.000155	0.000464	CcSEcCtD
Buprenorphine—Connective tissue disorder—Timolol—glaucoma	0.000155	0.000464	CcSEcCtD
Buprenorphine—Pruritus—Brimonidine—glaucoma	0.000154	0.000463	CcSEcCtD
Buprenorphine—Headache—Bimatoprost—glaucoma	0.000154	0.000463	CcSEcCtD
Buprenorphine—Nervous system disorder—Clonidine—glaucoma	0.000154	0.000462	CcSEcCtD
Buprenorphine—Hypersensitivity—Dorzolamide—glaucoma	0.000154	0.00046	CcSEcCtD
Buprenorphine—Tachycardia—Clonidine—glaucoma	0.000153	0.00046	CcSEcCtD
Buprenorphine—Hypersensitivity—Travoprost—glaucoma	0.000153	0.000458	CcSEcCtD
Buprenorphine—Skin disorder—Clonidine—glaucoma	0.000153	0.000458	CcSEcCtD
Buprenorphine—Hyperhidrosis—Clonidine—glaucoma	0.000152	0.000456	CcSEcCtD
Buprenorphine—Visual impairment—Timolol—glaucoma	0.000152	0.000455	CcSEcCtD
Buprenorphine—Malaise—Betaxolol—glaucoma	0.000151	0.000454	CcSEcCtD
Buprenorphine—Nausea—Apraclonidine—glaucoma	0.000151	0.000453	CcSEcCtD
Buprenorphine—Hypersensitivity—Brinzolamide—glaucoma	0.000151	0.000453	CcSEcCtD
Buprenorphine—Vertigo—Betaxolol—glaucoma	0.000151	0.000452	CcSEcCtD
Buprenorphine—Syncope—Betaxolol—glaucoma	0.00015	0.000451	CcSEcCtD
Buprenorphine—Dizziness—Acetazolamide—glaucoma	0.00015	0.000451	CcSEcCtD
Buprenorphine—Anorexia—Clonidine—glaucoma	0.00015	0.000449	CcSEcCtD
Buprenorphine—Asthenia—Dorzolamide—glaucoma	0.000149	0.000448	CcSEcCtD
Buprenorphine—Asthenia—Travoprost—glaucoma	0.000149	0.000446	CcSEcCtD
Buprenorphine—Palpitations—Betaxolol—glaucoma	0.000148	0.000445	CcSEcCtD
Buprenorphine—Pruritus—Dorzolamide—glaucoma	0.000147	0.000442	CcSEcCtD
Buprenorphine—Loss of consciousness—Betaxolol—glaucoma	0.000147	0.000442	CcSEcCtD
Buprenorphine—Eye disorder—Timolol—glaucoma	0.000147	0.000441	CcSEcCtD
Buprenorphine—Asthenia—Brinzolamide—glaucoma	0.000147	0.000441	CcSEcCtD
Buprenorphine—Hypotension—Clonidine—glaucoma	0.000147	0.000441	CcSEcCtD
Buprenorphine—Pruritus—Travoprost—glaucoma	0.000147	0.00044	CcSEcCtD
Buprenorphine—Tinnitus—Timolol—glaucoma	0.000147	0.00044	CcSEcCtD
Buprenorphine—Cough—Betaxolol—glaucoma	0.000146	0.000439	CcSEcCtD
Buprenorphine—Nausea—Bimatoprost—glaucoma	0.000146	0.000439	CcSEcCtD
Buprenorphine—Cardiac disorder—Timolol—glaucoma	0.000146	0.000438	CcSEcCtD
Buprenorphine—Hypersensitivity—Pilocarpine—glaucoma	0.000145	0.000435	CcSEcCtD
Buprenorphine—Pruritus—Brinzolamide—glaucoma	0.000145	0.000435	CcSEcCtD
Buprenorphine—Vomiting—Acetazolamide—glaucoma	0.000145	0.000433	CcSEcCtD
Buprenorphine—Dizziness—Brimonidine—glaucoma	0.000144	0.000433	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000143	0.00043	CcSEcCtD
Buprenorphine—Angiopathy—Timolol—glaucoma	0.000143	0.000428	CcSEcCtD
Buprenorphine—Myalgia—Betaxolol—glaucoma	0.000143	0.000428	CcSEcCtD
Buprenorphine—Chest pain—Betaxolol—glaucoma	0.000143	0.000428	CcSEcCtD
Buprenorphine—Arthralgia—Betaxolol—glaucoma	0.000143	0.000428	CcSEcCtD
Buprenorphine—Diarrhoea—Dorzolamide—glaucoma	0.000143	0.000428	CcSEcCtD
Buprenorphine—Headache—Acetazolamide—glaucoma	0.000142	0.000427	CcSEcCtD
Buprenorphine—Anxiety—Betaxolol—glaucoma	0.000142	0.000427	CcSEcCtD
Buprenorphine—Insomnia—Clonidine—glaucoma	0.000142	0.000427	CcSEcCtD
Buprenorphine—Immune system disorder—Timolol—glaucoma	0.000142	0.000426	CcSEcCtD
Buprenorphine—Diarrhoea—Travoprost—glaucoma	0.000142	0.000426	CcSEcCtD
Buprenorphine—Mediastinal disorder—Timolol—glaucoma	0.000142	0.000425	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000142	0.000425	CcSEcCtD
Buprenorphine—Asthenia—Pilocarpine—glaucoma	0.000141	0.000424	CcSEcCtD
Buprenorphine—Paraesthesia—Clonidine—glaucoma	0.000141	0.000423	CcSEcCtD
Buprenorphine—Discomfort—Betaxolol—glaucoma	0.000141	0.000423	CcSEcCtD
Buprenorphine—Dyspnoea—Clonidine—glaucoma	0.00014	0.00042	CcSEcCtD
Buprenorphine—Diarrhoea—Brinzolamide—glaucoma	0.00014	0.00042	CcSEcCtD
Buprenorphine—Somnolence—Clonidine—glaucoma	0.00014	0.000419	CcSEcCtD
Buprenorphine—Dry mouth—Betaxolol—glaucoma	0.00014	0.000419	CcSEcCtD
Buprenorphine—Pruritus—Pilocarpine—glaucoma	0.000139	0.000418	CcSEcCtD
Buprenorphine—Confusional state—Betaxolol—glaucoma	0.000138	0.000414	CcSEcCtD
Buprenorphine—Mental disorder—Timolol—glaucoma	0.000138	0.000414	CcSEcCtD
Buprenorphine—Dizziness—Dorzolamide—glaucoma	0.000138	0.000413	CcSEcCtD
Buprenorphine—Rash—Brimonidine—glaucoma	0.000138	0.000413	CcSEcCtD
Buprenorphine—Dermatitis—Brimonidine—glaucoma	0.000137	0.000412	CcSEcCtD
Buprenorphine—Dizziness—Travoprost—glaucoma	0.000137	0.000411	CcSEcCtD
Buprenorphine—Erythema—Timolol—glaucoma	0.000137	0.000411	CcSEcCtD
Buprenorphine—Malnutrition—Timolol—glaucoma	0.000137	0.000411	CcSEcCtD
Buprenorphine—Oedema—Betaxolol—glaucoma	0.000137	0.000411	CcSEcCtD
Buprenorphine—Headache—Brimonidine—glaucoma	0.000137	0.00041	CcSEcCtD
Buprenorphine—Decreased appetite—Clonidine—glaucoma	0.000137	0.00041	CcSEcCtD
Buprenorphine—Infection—Betaxolol—glaucoma	0.000136	0.000408	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Clonidine—glaucoma	0.000136	0.000407	CcSEcCtD
Buprenorphine—Fatigue—Clonidine—glaucoma	0.000136	0.000407	CcSEcCtD
Buprenorphine—Dizziness—Brinzolamide—glaucoma	0.000135	0.000406	CcSEcCtD
Buprenorphine—Nausea—Acetazolamide—glaucoma	0.000135	0.000405	CcSEcCtD
Buprenorphine—Diarrhoea—Pilocarpine—glaucoma	0.000135	0.000404	CcSEcCtD
Buprenorphine—Shock—Betaxolol—glaucoma	0.000135	0.000404	CcSEcCtD
Buprenorphine—Tension—Timolol—glaucoma	0.000134	0.000403	CcSEcCtD
Buprenorphine—Constipation—Clonidine—glaucoma	0.000134	0.000403	CcSEcCtD
Buprenorphine—Pain—Clonidine—glaucoma	0.000134	0.000403	CcSEcCtD
Buprenorphine—Nervous system disorder—Betaxolol—glaucoma	0.000134	0.000403	CcSEcCtD
Buprenorphine—Dysgeusia—Timolol—glaucoma	0.000134	0.000402	CcSEcCtD
Buprenorphine—Tachycardia—Betaxolol—glaucoma	0.000134	0.000401	CcSEcCtD
Buprenorphine—Nervousness—Timolol—glaucoma	0.000133	0.000399	CcSEcCtD
Buprenorphine—Skin disorder—Betaxolol—glaucoma	0.000133	0.000399	CcSEcCtD
Buprenorphine—Vomiting—Dorzolamide—glaucoma	0.000132	0.000397	CcSEcCtD
Buprenorphine—Hyperhidrosis—Betaxolol—glaucoma	0.000132	0.000397	CcSEcCtD
Buprenorphine—Rash—Dorzolamide—glaucoma	0.000131	0.000394	CcSEcCtD
Buprenorphine—Dermatitis—Dorzolamide—glaucoma	0.000131	0.000394	CcSEcCtD
Buprenorphine—Rash—Travoprost—glaucoma	0.000131	0.000392	CcSEcCtD
Buprenorphine—Dermatitis—Travoprost—glaucoma	0.000131	0.000392	CcSEcCtD
Buprenorphine—Headache—Dorzolamide—glaucoma	0.000131	0.000391	CcSEcCtD
Buprenorphine—Anorexia—Betaxolol—glaucoma	0.00013	0.000391	CcSEcCtD
Buprenorphine—Vomiting—Brinzolamide—glaucoma	0.00013	0.000391	CcSEcCtD
Buprenorphine—Dizziness—Pilocarpine—glaucoma	0.00013	0.00039	CcSEcCtD
Buprenorphine—Headache—Travoprost—glaucoma	0.00013	0.00039	CcSEcCtD
Buprenorphine—Nausea—Brimonidine—glaucoma	0.00013	0.000389	CcSEcCtD
Buprenorphine—Feeling abnormal—Clonidine—glaucoma	0.00013	0.000389	CcSEcCtD
Buprenorphine—Rash—Brinzolamide—glaucoma	0.000129	0.000387	CcSEcCtD
Buprenorphine—Vision blurred—Timolol—glaucoma	0.000129	0.000387	CcSEcCtD
Buprenorphine—Dermatitis—Brinzolamide—glaucoma	0.000129	0.000387	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Clonidine—glaucoma	0.000129	0.000386	CcSEcCtD
Buprenorphine—Headache—Brinzolamide—glaucoma	0.000128	0.000385	CcSEcCtD
Buprenorphine—Hypotension—Betaxolol—glaucoma	0.000128	0.000384	CcSEcCtD
Buprenorphine—Angioedema—Timolol—glaucoma	0.000125	0.000375	CcSEcCtD
Buprenorphine—Vomiting—Pilocarpine—glaucoma	0.000125	0.000375	CcSEcCtD
Buprenorphine—Urticaria—Clonidine—glaucoma	0.000125	0.000375	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000125	0.000374	CcSEcCtD
Buprenorphine—Abdominal pain—Clonidine—glaucoma	0.000124	0.000373	CcSEcCtD
Buprenorphine—Body temperature increased—Clonidine—glaucoma	0.000124	0.000373	CcSEcCtD
Buprenorphine—Rash—Pilocarpine—glaucoma	0.000124	0.000372	CcSEcCtD
Buprenorphine—Dermatitis—Pilocarpine—glaucoma	0.000124	0.000372	CcSEcCtD
Buprenorphine—Insomnia—Betaxolol—glaucoma	0.000124	0.000371	CcSEcCtD
Buprenorphine—Nausea—Dorzolamide—glaucoma	0.000124	0.000371	CcSEcCtD
Buprenorphine—Headache—Pilocarpine—glaucoma	0.000123	0.00037	CcSEcCtD
Buprenorphine—Nausea—Travoprost—glaucoma	0.000123	0.00037	CcSEcCtD
Buprenorphine—Vertigo—Timolol—glaucoma	0.000123	0.000369	CcSEcCtD
Buprenorphine—Paraesthesia—Betaxolol—glaucoma	0.000123	0.000369	CcSEcCtD
Buprenorphine—Syncope—Timolol—glaucoma	0.000123	0.000369	CcSEcCtD
Buprenorphine—Dyspnoea—Betaxolol—glaucoma	0.000122	0.000366	CcSEcCtD
Buprenorphine—Nausea—Brinzolamide—glaucoma	0.000122	0.000365	CcSEcCtD
Buprenorphine—Palpitations—Timolol—glaucoma	0.000121	0.000363	CcSEcCtD
Buprenorphine—Dyspepsia—Betaxolol—glaucoma	0.00012	0.000361	CcSEcCtD
Buprenorphine—Loss of consciousness—Timolol—glaucoma	0.00012	0.000361	CcSEcCtD
Buprenorphine—Cough—Timolol—glaucoma	0.00012	0.000359	CcSEcCtD
Buprenorphine—Decreased appetite—Betaxolol—glaucoma	0.000119	0.000357	CcSEcCtD
Buprenorphine—Hypertension—Timolol—glaucoma	0.000118	0.000355	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000118	0.000354	CcSEcCtD
Buprenorphine—Fatigue—Betaxolol—glaucoma	0.000118	0.000354	CcSEcCtD
Buprenorphine—Pain—Betaxolol—glaucoma	0.000117	0.000351	CcSEcCtD
Buprenorphine—Constipation—Betaxolol—glaucoma	0.000117	0.000351	CcSEcCtD
Buprenorphine—Nausea—Pilocarpine—glaucoma	0.000117	0.000351	CcSEcCtD
Buprenorphine—Arthralgia—Timolol—glaucoma	0.000117	0.00035	CcSEcCtD
Buprenorphine—Chest pain—Timolol—glaucoma	0.000117	0.00035	CcSEcCtD
Buprenorphine—Myalgia—Timolol—glaucoma	0.000117	0.00035	CcSEcCtD
Buprenorphine—Anxiety—Timolol—glaucoma	0.000116	0.000349	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000116	0.000347	CcSEcCtD
Buprenorphine—Hypersensitivity—Clonidine—glaucoma	0.000116	0.000347	CcSEcCtD
Buprenorphine—Discomfort—Timolol—glaucoma	0.000115	0.000346	CcSEcCtD
Buprenorphine—Dry mouth—Timolol—glaucoma	0.000114	0.000342	CcSEcCtD
Buprenorphine—Asthenia—Clonidine—glaucoma	0.000113	0.000338	CcSEcCtD
Buprenorphine—Feeling abnormal—Betaxolol—glaucoma	0.000113	0.000338	CcSEcCtD
Buprenorphine—Confusional state—Timolol—glaucoma	0.000113	0.000338	CcSEcCtD
Buprenorphine—Anaphylactic shock—Timolol—glaucoma	0.000112	0.000335	CcSEcCtD
Buprenorphine—Oedema—Timolol—glaucoma	0.000112	0.000335	CcSEcCtD
Buprenorphine—Pruritus—Clonidine—glaucoma	0.000111	0.000334	CcSEcCtD
Buprenorphine—Infection—Timolol—glaucoma	0.000111	0.000333	CcSEcCtD
Buprenorphine—Shock—Timolol—glaucoma	0.00011	0.00033	CcSEcCtD
Buprenorphine—Nervous system disorder—Timolol—glaucoma	0.00011	0.000329	CcSEcCtD
Buprenorphine—Urticaria—Betaxolol—glaucoma	0.000109	0.000326	CcSEcCtD
Buprenorphine—Skin disorder—Timolol—glaucoma	0.000109	0.000326	CcSEcCtD
Buprenorphine—Body temperature increased—Betaxolol—glaucoma	0.000108	0.000325	CcSEcCtD
Buprenorphine—Hyperhidrosis—Timolol—glaucoma	0.000108	0.000324	CcSEcCtD
Buprenorphine—Diarrhoea—Clonidine—glaucoma	0.000108	0.000323	CcSEcCtD
Buprenorphine—Anorexia—Timolol—glaucoma	0.000107	0.00032	CcSEcCtD
Buprenorphine—Hypotension—Timolol—glaucoma	0.000104	0.000313	CcSEcCtD
Buprenorphine—Dizziness—Clonidine—glaucoma	0.000104	0.000312	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Timolol—glaucoma	0.000102	0.000306	CcSEcCtD
Buprenorphine—Insomnia—Timolol—glaucoma	0.000101	0.000303	CcSEcCtD
Buprenorphine—Hypersensitivity—Betaxolol—glaucoma	0.000101	0.000302	CcSEcCtD
Buprenorphine—Paraesthesia—Timolol—glaucoma	0.0001	0.000301	CcSEcCtD
Buprenorphine—Vomiting—Clonidine—glaucoma	0.0001	0.0003	CcSEcCtD
Buprenorphine—Dyspnoea—Timolol—glaucoma	9.97e-05	0.000299	CcSEcCtD
Buprenorphine—Somnolence—Timolol—glaucoma	9.94e-05	0.000298	CcSEcCtD
Buprenorphine—Rash—Clonidine—glaucoma	9.91e-05	0.000297	CcSEcCtD
Buprenorphine—Dermatitis—Clonidine—glaucoma	9.9e-05	0.000297	CcSEcCtD
Buprenorphine—Headache—Clonidine—glaucoma	9.85e-05	0.000295	CcSEcCtD
Buprenorphine—Dyspepsia—Timolol—glaucoma	9.84e-05	0.000295	CcSEcCtD
Buprenorphine—Asthenia—Betaxolol—glaucoma	9.82e-05	0.000295	CcSEcCtD
Buprenorphine—Decreased appetite—Timolol—glaucoma	9.72e-05	0.000292	CcSEcCtD
Buprenorphine—Pruritus—Betaxolol—glaucoma	9.68e-05	0.00029	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Timolol—glaucoma	9.65e-05	0.00029	CcSEcCtD
Buprenorphine—Fatigue—Timolol—glaucoma	9.64e-05	0.000289	CcSEcCtD
Buprenorphine—Pain—Timolol—glaucoma	9.56e-05	0.000287	CcSEcCtD
Buprenorphine—Diarrhoea—Betaxolol—glaucoma	9.37e-05	0.000281	CcSEcCtD
Buprenorphine—Nausea—Clonidine—glaucoma	9.34e-05	0.00028	CcSEcCtD
Buprenorphine—Feeling abnormal—Timolol—glaucoma	9.22e-05	0.000276	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Timolol—glaucoma	9.14e-05	0.000274	CcSEcCtD
Buprenorphine—Dizziness—Betaxolol—glaucoma	9.05e-05	0.000271	CcSEcCtD
Buprenorphine—Urticaria—Timolol—glaucoma	8.88e-05	0.000266	CcSEcCtD
Buprenorphine—Abdominal pain—Timolol—glaucoma	8.84e-05	0.000265	CcSEcCtD
Buprenorphine—Body temperature increased—Timolol—glaucoma	8.84e-05	0.000265	CcSEcCtD
Buprenorphine—Vomiting—Betaxolol—glaucoma	8.7e-05	0.000261	CcSEcCtD
Buprenorphine—Rash—Betaxolol—glaucoma	8.63e-05	0.000259	CcSEcCtD
Buprenorphine—Dermatitis—Betaxolol—glaucoma	8.62e-05	0.000259	CcSEcCtD
Buprenorphine—Headache—Betaxolol—glaucoma	8.58e-05	0.000257	CcSEcCtD
Buprenorphine—Hypersensitivity—Timolol—glaucoma	8.24e-05	0.000247	CcSEcCtD
Buprenorphine—Nausea—Betaxolol—glaucoma	8.13e-05	0.000244	CcSEcCtD
Buprenorphine—Asthenia—Timolol—glaucoma	8.02e-05	0.000241	CcSEcCtD
Buprenorphine—Pruritus—Timolol—glaucoma	7.91e-05	0.000237	CcSEcCtD
Buprenorphine—Diarrhoea—Timolol—glaucoma	7.65e-05	0.000229	CcSEcCtD
Buprenorphine—Dizziness—Timolol—glaucoma	7.39e-05	0.000222	CcSEcCtD
Buprenorphine—Vomiting—Timolol—glaucoma	7.11e-05	0.000213	CcSEcCtD
Buprenorphine—Rash—Timolol—glaucoma	7.05e-05	0.000211	CcSEcCtD
Buprenorphine—Dermatitis—Timolol—glaucoma	7.04e-05	0.000211	CcSEcCtD
Buprenorphine—Headache—Timolol—glaucoma	7.01e-05	0.00021	CcSEcCtD
Buprenorphine—Nausea—Timolol—glaucoma	6.64e-05	0.000199	CcSEcCtD
Buprenorphine—CYP3A5—Metabolism—CTSA—glaucoma	3.03e-05	0.000484	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.03e-05	0.000483	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3e-05	0.000479	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—EDN1—glaucoma	2.99e-05	0.000477	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NARFL—glaucoma	2.98e-05	0.000476	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CA5A—glaucoma	2.98e-05	0.000476	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—C3—glaucoma	2.98e-05	0.000476	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.9e-05	0.000463	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CA2—glaucoma	2.87e-05	0.000457	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—TXN—glaucoma	2.82e-05	0.00045	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—TXN—glaucoma	2.79e-05	0.000446	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SMO—glaucoma	2.78e-05	0.000443	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—EDN1—glaucoma	2.72e-05	0.000434	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CA1—glaucoma	2.71e-05	0.000433	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.71e-05	0.000432	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—C3—glaucoma	2.71e-05	0.000432	CbGpPWpGaD
Buprenorphine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.67e-05	0.000427	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HDAC9—glaucoma	2.63e-05	0.00042	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CTSA—glaucoma	2.63e-05	0.000419	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—C3—glaucoma	2.61e-05	0.000417	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—NOS3—glaucoma	2.61e-05	0.000417	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CYP1B1—glaucoma	2.6e-05	0.000414	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ABCA1—glaucoma	2.6e-05	0.000414	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GSTT1—glaucoma	2.57e-05	0.000411	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—TXN—glaucoma	2.56e-05	0.000408	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NTRK2—glaucoma	2.54e-05	0.000405	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—EDN1—glaucoma	2.53e-05	0.000403	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CA2—glaucoma	2.48e-05	0.000396	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SMO—glaucoma	2.43e-05	0.000388	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.43e-05	0.000387	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.43e-05	0.000387	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CA1—glaucoma	2.42e-05	0.000386	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—C3—glaucoma	2.37e-05	0.000379	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CA1—glaucoma	2.36e-05	0.000377	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CTSA—glaucoma	2.35e-05	0.000374	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—EDN1—glaucoma	2.3e-05	0.000366	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CTSA—glaucoma	2.29e-05	0.000365	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	2.28e-05	0.000364	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CDKN1B—glaucoma	2.26e-05	0.000361	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CA1—glaucoma	2.23e-05	0.000355	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NTRK2—glaucoma	2.23e-05	0.000355	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CA2—glaucoma	2.22e-05	0.000353	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—C3—glaucoma	2.21e-05	0.000352	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CA1—glaucoma	2.21e-05	0.000352	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GSTT1—glaucoma	2.18e-05	0.000349	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NGFR—glaucoma	2.18e-05	0.000348	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GSTT1—glaucoma	2.17e-05	0.000345	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.16e-05	0.000345	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.16e-05	0.000345	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CA2—glaucoma	2.16e-05	0.000345	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.16e-05	0.000345	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CTSA—glaucoma	2.16e-05	0.000344	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CTSA—glaucoma	2.14e-05	0.000341	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MMP9—glaucoma	2.1e-05	0.000334	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.08e-05	0.000331	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GSTM1—glaucoma	2.07e-05	0.000331	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NTRK1—glaucoma	2.07e-05	0.00033	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SMO—glaucoma	2.06e-05	0.000328	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CYP1B1—glaucoma	2.05e-05	0.000327	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ABCA1—glaucoma	2.05e-05	0.000327	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CA2—glaucoma	2.04e-05	0.000325	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CA2—glaucoma	2.02e-05	0.000322	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—TXN—glaucoma	2.02e-05	0.000322	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—C3—glaucoma	2.01e-05	0.00032	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GSTT1—glaucoma	1.98e-05	0.000317	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.97e-05	0.000315	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.97e-05	0.000315	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NGFR—glaucoma	1.91e-05	0.000305	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CDKN2B—glaucoma	1.91e-05	0.000304	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CA1—glaucoma	1.89e-05	0.000301	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—VEGFA—glaucoma	1.88e-05	0.0003	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NTRK2—glaucoma	1.88e-05	0.0003	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—MTHFR—glaucoma	1.83e-05	0.000293	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—EDN1—glaucoma	1.83e-05	0.000292	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CTSA—glaucoma	1.83e-05	0.000292	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NTRK1—glaucoma	1.82e-05	0.00029	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.8e-05	0.000287	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—TXN—glaucoma	1.75e-05	0.000279	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CYP1B1—glaucoma	1.74e-05	0.000278	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ABCA1—glaucoma	1.74e-05	0.000278	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CA2—glaucoma	1.73e-05	0.000275	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ABCA1—glaucoma	1.73e-05	0.000275	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CYP1B1—glaucoma	1.73e-05	0.000275	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—APOE—glaucoma	1.71e-05	0.000272	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CAV1—glaucoma	1.69e-05	0.00027	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.69e-05	0.000269	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.69e-05	0.000269	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NGF—glaucoma	1.68e-05	0.000268	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CDKN2B—glaucoma	1.67e-05	0.000267	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GSTM1—glaucoma	1.64e-05	0.000262	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NGFR—glaucoma	1.61e-05	0.000258	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—EDN1—glaucoma	1.61e-05	0.000256	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—C3—glaucoma	1.6e-05	0.000255	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.6e-05	0.000255	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ABCA1—glaucoma	1.58e-05	0.000252	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CYP1B1—glaucoma	1.58e-05	0.000252	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.58e-05	0.000252	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GSTT1—glaucoma	1.57e-05	0.00025	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—TXN—glaucoma	1.56e-05	0.000249	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.54e-05	0.000246	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NTRK1—glaucoma	1.53e-05	0.000245	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—TXN—glaucoma	1.52e-05	0.000243	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—APOE—glaucoma	1.49e-05	0.000238	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NGF—glaucoma	1.47e-05	0.000235	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CAV1—glaucoma	1.47e-05	0.000235	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CA1—glaucoma	1.46e-05	0.000232	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—MTHFR—glaucoma	1.45e-05	0.000231	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—TXN—glaucoma	1.44e-05	0.000229	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.42e-05	0.000227	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—TXN—glaucoma	1.42e-05	0.000227	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TP53—glaucoma	1.42e-05	0.000227	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CDKN2B—glaucoma	1.41e-05	0.000226	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.41e-05	0.000225	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CTSA—glaucoma	1.41e-05	0.000225	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—FN1—glaucoma	1.4e-05	0.000224	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—C3—glaucoma	1.4e-05	0.000224	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GSTM1—glaucoma	1.39e-05	0.000222	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—BAD—glaucoma	1.39e-05	0.000221	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GSTM1—glaucoma	1.38e-05	0.00022	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.36e-05	0.000217	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—EDN1—glaucoma	1.36e-05	0.000216	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GSTT1—glaucoma	1.36e-05	0.000216	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—APOE—glaucoma	1.35e-05	0.000215	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CAV1—glaucoma	1.34e-05	0.000213	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CA2—glaucoma	1.33e-05	0.000213	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—APOE—glaucoma	1.31e-05	0.000208	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.3e-05	0.000207	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CAV1—glaucoma	1.29e-05	0.000206	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.29e-05	0.000205	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—NOS3—glaucoma	1.28e-05	0.000204	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GSTM1—glaucoma	1.26e-05	0.000202	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ABCA1—glaucoma	1.25e-05	0.000199	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CYP1B1—glaucoma	1.25e-05	0.000199	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NGF—glaucoma	1.25e-05	0.000199	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—FN1—glaucoma	1.23e-05	0.000196	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—MTHFR—glaucoma	1.23e-05	0.000196	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—MTHFR—glaucoma	1.22e-05	0.000194	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—BAD—glaucoma	1.22e-05	0.000194	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—TXN—glaucoma	1.22e-05	0.000194	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTT1—glaucoma	1.21e-05	0.000193	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—C3—glaucoma	1.19e-05	0.000189	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTT1—glaucoma	1.18e-05	0.000188	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTGS2—glaucoma	1.17e-05	0.000187	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—APOE—glaucoma	1.14e-05	0.000183	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—APOE—glaucoma	1.13e-05	0.000181	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CAV1—glaucoma	1.13e-05	0.000181	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CAV1—glaucoma	1.12e-05	0.000179	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MTHFR—glaucoma	1.12e-05	0.000178	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NOS3—glaucoma	1.12e-05	0.000178	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTT1—glaucoma	1.11e-05	0.000178	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.11e-05	0.000177	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTT1—glaucoma	1.1e-05	0.000176	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—APOE—glaucoma	1.1e-05	0.000176	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.1e-05	0.000175	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.09e-05	0.000174	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CAV1—glaucoma	1.09e-05	0.000174	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ABCA1—glaucoma	1.08e-05	0.000172	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP1B1—glaucoma	1.08e-05	0.000172	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—FN1—glaucoma	1.04e-05	0.000166	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—APOE—glaucoma	1.04e-05	0.000166	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CAV1—glaucoma	1.03e-05	0.000164	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—BAD—glaucoma	1.03e-05	0.000164	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—NOS3—glaucoma	1.01e-05	0.000161	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GSTM1—glaucoma	9.97e-06	0.000159	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NOS3—glaucoma	9.78e-06	0.000156	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.76e-06	0.000156	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CDKN1B—glaucoma	9.66e-06	0.000154	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP1B1—glaucoma	9.64e-06	0.000154	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ABCA1—glaucoma	9.64e-06	0.000154	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTT1—glaucoma	9.43e-06	0.00015	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP1B1—glaucoma	9.41e-06	0.00015	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ABCA1—glaucoma	9.41e-06	0.00015	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—TXN—glaucoma	9.38e-06	0.00015	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGS2—glaucoma	9.25e-06	0.000148	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MMP9—glaucoma	8.95e-06	0.000143	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.9e-06	0.000142	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ABCA1—glaucoma	8.87e-06	0.000141	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP1B1—glaucoma	8.87e-06	0.000141	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MTHFR—glaucoma	8.81e-06	0.000141	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ABCA1—glaucoma	8.79e-06	0.00014	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP1B1—glaucoma	8.79e-06	0.00014	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GSTM1—glaucoma	8.64e-06	0.000138	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—NOS3—glaucoma	8.58e-06	0.000137	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—NOS3—glaucoma	8.5e-06	0.000136	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CDKN1B—glaucoma	8.47e-06	0.000135	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NOS3—glaucoma	8.27e-06	0.000132	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—APOE—glaucoma	8.2e-06	0.000131	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CAV1—glaucoma	8.13e-06	0.00013	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—VEGFA—glaucoma	8.04e-06	0.000128	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MMP9—glaucoma	7.85e-06	0.000125	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS2—glaucoma	7.84e-06	0.000125	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—NOS3—glaucoma	7.79e-06	0.000124	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS2—glaucoma	7.78e-06	0.000124	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTM1—glaucoma	7.71e-06	0.000123	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MTHFR—glaucoma	7.63e-06	0.000122	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.6e-06	0.000121	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTM1—glaucoma	7.52e-06	0.00012	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ABCA1—glaucoma	7.51e-06	0.00012	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP1B1—glaucoma	7.51e-06	0.00012	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTT1—glaucoma	7.28e-06	0.000116	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CDKN1B—glaucoma	7.16e-06	0.000114	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—glaucoma	7.13e-06	0.000114	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOE—glaucoma	7.1e-06	0.000113	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTM1—glaucoma	7.09e-06	0.000113	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—VEGFA—glaucoma	7.05e-06	0.000112	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CAV1—glaucoma	7.04e-06	0.000112	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTM1—glaucoma	7.03e-06	0.000112	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MTHFR—glaucoma	6.81e-06	0.000109	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MTHFR—glaucoma	6.65e-06	0.000106	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MMP9—glaucoma	6.63e-06	0.000106	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOE—glaucoma	6.34e-06	0.000101	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CAV1—glaucoma	6.28e-06	0.0001	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MTHFR—glaucoma	6.27e-06	0.0001	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MTHFR—glaucoma	6.21e-06	9.91e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOE—glaucoma	6.19e-06	9.88e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—NOS3—glaucoma	6.15e-06	9.81e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CAV1—glaucoma	6.13e-06	9.79e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TP53—glaucoma	6.07e-06	9.69e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTM1—glaucoma	6.01e-06	9.58e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—VEGFA—glaucoma	5.95e-06	9.5e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOE—glaucoma	5.83e-06	9.31e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP1B1—glaucoma	5.8e-06	9.25e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ABCA1—glaucoma	5.8e-06	9.25e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOE—glaucoma	5.78e-06	9.23e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CAV1—glaucoma	5.78e-06	9.22e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CAV1—glaucoma	5.73e-06	9.14e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—glaucoma	5.62e-06	8.97e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TP53—glaucoma	5.32e-06	8.49e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—NOS3—glaucoma	5.32e-06	8.49e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MTHFR—glaucoma	5.31e-06	8.47e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOE—glaucoma	4.94e-06	7.88e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CAV1—glaucoma	4.9e-06	7.81e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—glaucoma	4.87e-06	7.77e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NOS3—glaucoma	4.75e-06	7.58e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NOS3—glaucoma	4.64e-06	7.4e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTM1—glaucoma	4.63e-06	7.4e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TP53—glaucoma	4.5e-06	7.18e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NOS3—glaucoma	4.37e-06	6.97e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—glaucoma	4.35e-06	6.93e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NOS3—glaucoma	4.33e-06	6.91e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—glaucoma	4.24e-06	6.77e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MTHFR—glaucoma	4.1e-06	6.54e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—glaucoma	4e-06	6.38e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—glaucoma	3.96e-06	6.32e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOE—glaucoma	3.81e-06	6.08e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CAV1—glaucoma	3.78e-06	6.03e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NOS3—glaucoma	3.7e-06	5.91e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—glaucoma	3.39e-06	5.4e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NOS3—glaucoma	2.86e-06	4.56e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—glaucoma	2.61e-06	4.17e-05	CbGpPWpGaD
